Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

A long non-coding RNA, PTCSC3, as a tumor suppressor and a target of miRNAs in thyroid cancer cells.

Fan M, Li X, Jiang W, Huang Y, Li J, Wang Z.

Exp Ther Med. 2013 Apr;5(4):1143-1146.

2.

MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer.

Geraldo MV, Yamashita AS, Kimura ET.

Oncogene. 2012 Apr 12;31(15):1910-22. doi: 10.1038/onc.2011.381.

PMID:
21874046
3.

The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type.

Jendrzejewski J, He H, Radomska HS, Li W, Tomsic J, Liyanarachchi S, Davuluri RV, Nagy R, de la Chapelle A.

Proc Natl Acad Sci U S A. 2012 May 29;109(22):8646-51. doi: 10.1073/pnas.1205654109.

4.

Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells.

Takakura S, Mitsutake N, Nakashima M, Namba H, Saenko VA, Rogounovitch TI, Nakazawa Y, Hayashi T, Ohtsuru A, Yamashita S.

Cancer Sci. 2008 Jun;99(6):1147-54. doi: 10.1111/j.1349-7006.2008.00800.x.

5.

PTCSC3 Is Involved in Papillary Thyroid Carcinoma Development by Modulating S100A4 Gene Expression.

Jendrzejewski J, Thomas A, Liyanarachchi S, Eiterman A, Tomsic J, He H, Radomska HS, Li W, Nagy R, Sworczak K, de la Chapelle A.

J Clin Endocrinol Metab. 2015 Oct;100(10):E1370-7. doi: 10.1210/jc.2015-2247.

6.

MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.

Chen YT, Kitabayashi N, Zhou XK, Fahey TJ 3rd, Scognamiglio T.

Mod Pathol. 2008 Sep;21(9):1139-46. doi: 10.1038/modpathol.2008.105.

7.

miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP.

Zhu W, Xu H, Zhu D, Zhi H, Wang T, Wang J, Jiang B, Shu Y, Liu P.

Cancer Chemother Pharmacol. 2012 Mar;69(3):723-31. doi: 10.1007/s00280-011-1752-3.

PMID:
21993663
8.

MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines.

Takahashi Y, Forrest AR, Maeno E, Hashimoto T, Daub CO, Yasuda J.

PLoS One. 2009 Aug 18;4(8):e6677. doi: 10.1371/journal.pone.0006677.

9.

Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines.

Mitomo S, Maesawa C, Ogasawara S, Iwaya T, Shibazaki M, Yashima-Abo A, Kotani K, Oikawa H, Sakurai E, Izutsu N, Kato K, Komatsu H, Ikeda K, Wakabayashi G, Masuda T.

Cancer Sci. 2008 Feb;99(2):280-6. doi: 10.1111/j.1349-7006.2007.00666.x.

10.

Identification of novel gene expression targets for the Ras association domain family 1 (RASSF1A) tumor suppressor gene in non-small cell lung cancer and neuroblastoma.

Agathanggelou A, Bièche I, Ahmed-Choudhury J, Nicke B, Dammann R, Baksh S, Gao B, Minna JD, Downward J, Maher ER, Latif F.

Cancer Res. 2003 Sep 1;63(17):5344-51.

11.

BRAF-Activated Long Noncoding RNA Modulates Papillary Thyroid Carcinoma Cell Proliferation through Regulating Thyroid Stimulating Hormone Receptor.

Zheng H, Wang M, Jiang L, Chu H, Hu J, Ning J, Li B, Wang D, Xu J.

Cancer Res Treat. 2016 Apr;48(2):698-707. doi: 10.4143/crt.2015.118.

12.

Differential miRNA expression and their target genes between NGX6-positive and negative colon cancer cells.

Wang XY, Wu MH, Liu F, Li Y, Li N, Li GY, Shen SR.

Mol Cell Biochem. 2010 Dec;345(1-2):283-90. doi: 10.1007/s11010-010-0582-7.

PMID:
20859756
13.

Regulating A549 cells growth by ASO inhibiting miRNA expression.

Wang PY, Li YJ, Zhang S, Li ZL, Yue Z, Xie N, Xie SY.

Mol Cell Biochem. 2010 Jun;339(1-2):163-71. doi: 10.1007/s11010-009-0380-2.

PMID:
20049626
14.

MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma.

Redova M, Poprach A, Besse A, Iliev R, Nekvindova J, Lakomy R, Radova L, Svoboda M, Dolezel J, Vyzula R, Slaby O.

Tumour Biol. 2013 Feb;34(1):481-91. doi: 10.1007/s13277-012-0573-2.

PMID:
23150176
15.

miRNA-21 regulates arsenic-induced anti-leukemia activity in myelogenous cell lines.

Gu J, Zhu X, Li Y, Dong D, Yao J, Lin C, Huang K, Hu H, Fei J.

Med Oncol. 2011 Mar;28(1):211-8. doi: 10.1007/s12032-009-9413-7.

PMID:
20143188
16.

[Effect of microRNA on proliferation caused by mutant HBx in human hepatocytes].

Fu XY, Tan DM, Hou ZH, Hu ZL, Liu GZ, Ouyang Y, Liu F.

Zhonghua Gan Zang Bing Za Zhi. 2012 Aug;20(8):598-604. doi: 10.3760/cma.j.issn.1007-3418.2012.08.012. Chinese.

PMID:
23207154
17.

miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF.

Sun CY, She XM, Qin Y, Chu ZB, Chen L, Ai LS, Zhang L, Hu Y.

Carcinogenesis. 2013 Feb;34(2):426-35. doi: 10.1093/carcin/bgs333.

18.

Identification of a new microRNA expression profile as a potential cancer screening tool.

Roa W, Brunet B, Guo L, Amanie J, Fairchild A, Gabos Z, Nijjar T, Scrimger R, Yee D, Xing J.

Clin Invest Med. 2010 Apr 1;33(2):E124.

PMID:
20370992
19.

Tumor-suppressive mir-663 gene induces mitotic catastrophe growth arrest in human gastric cancer cells.

Pan J, Hu H, Zhou Z, Sun L, Peng L, Yu L, Sun L, Liu J, Yang Z, Ran Y.

Oncol Rep. 2010 Jul;24(1):105-12.

PMID:
20514450
20.

The proto-oncogene Pim-1 is a target of miR-33a.

Thomas M, Lange-Grünweller K, Weirauch U, Gutsch D, Aigner A, Grünweller A, Hartmann RK.

Oncogene. 2012 Feb 16;31(7):918-28. doi: 10.1038/onc.2011.278.

PMID:
21743487
Items per page

Supplemental Content

Support Center